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The value of fine needle aspiration 
cytology in the clinical management 
of rare salivary gland tumors
Salivary gland tumors are relatively rare neoplasms, mostly located in 
the parotid gland, and few are malignant. Preoperative evaluation of salivary 
gland tumors includes fine needle aspiration cytology (FNAC). Objective: 
The purpose of this study was to determine the importance of FNAC in the 
evaluation of rare salivary gland neoplasms. Material and Methods: Four 
cases of rare salivary gland tumors were included, which were preoperatively 
assessed by clinical investigation, computed tomography, and FNAC. Results: 
The presented cases include myoepithelial carcinoma, oncocytic carcinoma, 
undifferentiated lymphoepithelial carcinoma, and marginal zone lymphoma. 
Conclusion: FNAC is a reliable diagnostic tool for common salivary gland 
neoplasms; however, rare tumors often represent diagnostic challenges. 
Clinical relevance: In such rare tumors, the role of aspiration cytology may 
be limited to establishing the dignity of the lesion (benign/malignant). This 
knowledge enables the surgeon to choose the most appropriate therapeutic 
procedure. A definitive diagnosis of rare tumors (either epithelial or non-
epithelial) is obtained by histological examination; cytology is limited in this 
regard due to overlapping features.
Keywords: Salivary gland neoplasms. Rare malignancies. Aspiration 
cytology. Cytopathology.
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Introduction
Salivary gland tumors are relatively rare neoplasms, 
with an incidence of about 2.5-3 cases per 100,000, 
and represent about 3% of all head and neck tumors. 
Most salivary gland tumors are in the parotid gland 
(75-80%) and only 20% of them are malignant5,26. 
Etiology of salivary gland tumors is still under debate; 
it is presumed that smoking, viral infections, and 
genetic predisposition may all play a significant role 
in their pathogenesis. Ionizing radiation is probably 
the only well-established risk factor with documented 
role in the etiology of these tumors15,32.
The initial preoperative evaluation of salivary gland 
tumors includes patient history, followed by thorough 
clinical examination of the face and neck, imaging 
tests (especially ultrasonography and computed 
tomography), and fine-needle aspiration cytology 
(FNAC). FNAC is a preferred method for obtaining 
morphological diagnosis prior to surgery. It is relatively 
low cost, less invasive, and has the ability to offer 
preoperative diagnosis, which makes it a preferred 
method of diagnosis. FNAC is effective in providing 
rapid morphological assessment of lesions, offering 
valuable information about the origin (salivary or non-
salivary), nature (benign or malignant) and/or grade 
(low or high grade) of the tumors. Information thus 
obtained is an invaluable aid in proper clinical and 
surgical management4,6.
Although this is valid for most cases, cytology 
alone, however, cannot provide a definitive diagnosis 
in some cases where histological diagnosis is the 
gold standard. FNAC has limitations, especially in 
identifying rare entities and distinguishing lesions that 
have overlapping cytological features, which is often 
the case in salivary gland tumors3.
The World Health Organization classifies salivary 
gland epithelial tumors into 10 benign and 23 
malignant entities. Non-epithelial neoplasms are rare, 
representing about 2-5% of all salivary gland tumors. 
This complex classification is based on histological 
features and has the advantage of estimating the 
prognostic and therapeutic outcomes based on the 
different behavior of each tumor type. The great 
diversity of these tumors is related to various cell types 
found in salivary glands (ductal, acinar, myoepithelial, 
and basal cell types)5. This plethora of diverse types, 
however, also turns FNAC diagnosis into a challenging 
task.
The purpose of this study was to highlight the role 
of FNAC in the evaluation and clinical management 
of rare salivary gland neoplasms, with emphasis on a 
multidisciplinary approach.
Material and methods
Four patients included in this study were hospitalized 
in the Department of Oral and Maxillofacial Surgery 
of the Mures County Emergency Clinic (Spitalul 
Clinic Judetean de Urgenta Mures); cytological and 
histological diagnosis were conducted at the Pathology 
Laboratory of the same hospital. Upon submission, a 
signed written informed consent was obtained from all 
four patients. No additional tissues/cells were removed 
from any patient, other than what was necessary for 
accurate cytological/histological diagnosis.
Cytological material was obtained using standard 
FNAC technique. An average of three passes per 
patient was performed, each resulting in one or two 
smears. A Cameco-type syringe holder fastened with 
a 10-ml three-piece syringe and a 23G needle was 
used. The aspired material was spread on standard 
pre-cleaned glass slides (Menzel-Glaser Superfrost, 
Braunschweig, Germany) using the standard one-step 
method. Wet-fixation (immediate immersion into 95% 
ethyl alcohol) and standard Papanicolaou staining 
was used. Histological specimens were prepared from 
surgically removed tissues. Standard hematoxylin-
eosin staining was applied, with the use of additional 
immunohistochemical markers, as mentioned later.
The study complies with the recommendations of 
the Helsinki Declaration guidelines, and it was approved 
by the ethics committee of our university. The identity 
of the patients was protected at several levels. From 
their clinical data, only tumor localization, size, age, 
sex, cytology diagnosis, and histopathological type 
were used. Patient confidentiality was respected by 
anonymizing biopsy specimens.
Results, case series
Case 1
A 92-year-old male patient presented at the 
Department of Oral and Maxillofacial Surgery due to 
a right parotid painless mass, clinically suggestive 
of a malignant neoplasm, present for the past six to 
seven months, with recently developed facial paresis. 
The value of fine needle aspiration cytology in the clinical management of rare salivary gland tumors
J Appl Oral Sci. 2018;26:e201702673/11
Physical examination showed a tumor of about 6 cm in 
its greatest diameter, with diffuse, irregular palpatory 
appearance, fixed to underlying structures, covered 
by normal skin. Computed Tomography (CT) showed 
a tumor mass extending into the right parotid gland 
parenchyma, without invasion of adjacent maxillary 
structures and lateral-cervical lymphadenopathy. 
Preoperative FNAC resulted in moderately cellular 
smears, composed of polymorphous lymphocytes and 
many atypical cells with large, hyperchromatic nuclei, 
some lacking cytoplasm, suggesting a malignant 
neoplasm. Atypical cells displayed characteristics 
of epithelial cells with moderate atypia (Figure 1). 
Relatively scant stromal elements were seen. No 
specific features of common entities were observed; 
however, the malignant nature of the lesion was 
obvious. The patient underwent total parotidectomy 
with facial nerve resection because intraoperatively 
the nerve was found to be embedded into the tumor. 
Histopathology showed a multinodular neoplastic 
process with infiltrative margins in the right parotid 
parenchyma, with the effacement of normal ducto-
acinar structures. A proliferation of fusiform cells, 
some displaying epithelioid features, with marked 
nuclear pleomorphism and atypical mitoses, were 
seen. Markedly hyaline stroma and widespread areas 
of the perineural invasion were also present (Figure 
2). Tumor cells displayed positivity for cytokeratins 
5/6 and 7, smooth muscle antigen (SMA), S100 and 
p63 proteins, and were negative for desmin, thus 
indicating the myoepithelial origin. A diagnosis of the 
myoepithelial carcinoma was made, and the patient 
was referred to the Oncology Department for further 
treatment; but unfortunately, he refused any further 
therapy, and has no longer presented for clinical 
follow-up.
Case 2
A 62-year-old female was referred to the clinic for 
a painless, slow growing, upper right lateral-cervical 
nodular mass. Physical examination showed a firm, 
fixed mass, measuring about 10 cm in greatest 
diameter, located at the inferior pole of the right parotid 
gland without facial nerve involvement or lymph node 
enlargement (Figure 3). The patient had congestive 
heart failure, atrial fibrillation, and chronic obstructive 
pulmonary disease. Computed tomography described 
the tumor as extending to the upper third of the lateral-
cervical region and inferior pole of the right parotid, 
with extension to the sternocleidomastoid muscle and 
the carotid-jugular vascular bundle and neighboring 
structures. FNAC showed numerous neoplastic cells 
with oncocytic change (finely granular eosinophilic 
cytoplasm, well defined cytoplasmic borders, slightly 
discohesive, moderately eccentric nuclei), many nuclei 
lacking cytoplasm, with moderate nuclear atypia and 
an associated but reduced lymphocytic population 
(Figure 4). It was diagnosed as an oncocytic tumor. 
The patient’s severely altered general condition (stage 
IV tumor), associated diseases (chronic cardiac failure, 
Figure 1- Myoepithelial carcinoma, cytology. Smears have rich cellularity and are dominated by polygonal pleomorphic tumor cells with 
abundant delicate cytoplasm. Nuclear atypia in the form of hyperchromasia, coarse chromatine distribution, and occasional large nuclei 
are observed. Neoplastic cells occasionally form cohesive clusters, and isolated cells are frequently seen. Cell non-neoplastic small 
mature lymphocytes are also observed. Background is hemorrhagic. (obj. 20×, Papanicolaou stain)
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chronic obstructive pulmonary disease) precluded a 
more aggressive surgical approach. In this setting, a 
FNAC followed by incisional biopsy was performed.
Histological examination revealed muscular, 
connective, and fatty tissues infiltration by proliferating 
tumor cells, tumor cells arranged in solid structures 
without secondary lumen formation, occasionally with 
discohesive growth pattern with foci of perineural 
invasion. The tumor cells were large, with abundant, 
finely vacuolated, eosinophilic cytoplasm, with large 
central, vesicular nuclei, and prominent, eosinophilic 
nucleoli. Numerous mitoses and a relatively abundant 
inflammatory infiltrate were observed. Tumor cells 
expressed cytokeratins AE1/AE3 and 7, and were 
negative for cytokeratin 20, S100 protein, and 
HMB45. The final histological diagnosis was oncocytic 
carcinoma. The patient refused surgery due to her 
associated diseases and was referred for palliative 
oncology. She underwent adjuvant radiotherapy – 70 
Gy in 35 sessions. She presented only once for clinical 
Figure 2- Myoepithelial carcinoma, histology. The tumor shows a somewhat nodular and solid growth pattern. Tumor cells exhibit clear cut 
pleomorphism; many of them showing epithelial morphology or fusiform shape, vacuolated cytoplasm with eosinophilic and some myxoid 
material in the background. (obj. 20×, hematoxylin and eosin stain)
Figure 3- Oncocytic carcinoma, clinical aspect. A right-sided subcutaneous inferior retro-auricular mass is observed, with a somewhat 
bosselated surface. Overlying skin is shiny and shows a bluish red discoloration. (Face partially blurred for patient privacy)
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follow-up, one month after radiotherapy. Her general 
condition had improved slightly.
Case 3
A 66-year-old male patient presented with facial 
asymmetry caused by a painless mass on the right 
parotid area, discovered a year ago, that showed 
accelerated growth in the past four months. Clinical 
examination revealed a firm, irregular, 5 cm diameter 
mass arising in the right pre-auricular region, fixed 
to deeper tissues and overlying skin, without clinical 
evidence of facial nerve involvement. Ultrasonography 
showed a hypoechogenic mass of 40×33 mm 
with irregular contour, heterogeneous structure, 
and rich vascular image, confirmed by computed 
tomography as well, without lymph node involvement. 
FNAC described atypical epithelial cells with large, 
hyperchromic nuclei in a rich lymphocytic background 
and many histiocytes of foamy cytoplasm with tumor 
diathesis. A diagnosis of undifferentiated carcinoma 
Figure 4- Oncocytic carcinoma, cytology. A group of oncocytic cell is observed. The cells show moderate nuclear atypia (hyperchromasia, 
slight nuclear membrane irregularities, anisonucleosis). The cells have abundant finely granular eosinophilic cytoplasm, nuclei are 
eccentrically located (obj. 40×, Papanicolaou stain)
Figure 5- Undifferentiated lymphoepithelial carcinoma, cytology. Smears showed high cellularity composed of aggregates of atypical 
epithelial cells in a background of mature lymphocytes. Neoplastic cells are predominantly found as cohesive clusters with scattered 
isolated cells at the periphery. Atypical cells having poorly defined cytoplasmic borders, large vesicular nucleus, finely granular chromatin, 
occasionally with single prominent nucleolus. (obj. 20×, Papanicolaou stain)
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was assessed on the cytological examination (Figure 
5). Two surgical interventions were performed. Firstly, 
since no pathological lymph node enlargement was 
observed on initial CT scan, total parotidectomy was 
performed. Superior lateral-cervical lymph node 
enlargement was observed six months after the initial 
surgery, and was confirmed by subsequent CT scan. 
Right selective neck dissection was performed in 
accordance with current protocols for the treatment 
of malignant parotid tumors.
Histopathology revealed a tumor consisting on 
large clusters of atypical cells with indistinct margins, 
frequently displaying syncytial appearance. The 
tumor cells had scanty cytoplasm, large, vesicular 
nuclei, and prominent nucleoli. Numerous atypical 
mitoses were seen. The cellular islands showed central 
necrosis and abundant inflammatory infiltrate at the 
periphery. Small mature lymphocytes were also found 
scattered among tumor cells (Figure 6). Residual 
parotid parenchyma containing two lymph nodes, 
one with tumor invasion, was also present. The tumor 
presented lymphovascular and perineural invasion. 
Tumor cells were positive only for cytokeratin AE1/
AE3, and negative for cytokeratin 5/6 and 7, p63, 
SMA, PS100, chromogranin, and synaptophysin. The 
final diagnosis was undifferentiated lymphoepithelial 
carcinoma. The patient underwent radiotherapy (70 
Gy in 35 sessions), returned for regular clinical checks 
every 3 months in the first year, and then disappeared. 
During these visits, his general condition seemed to 
Figure 6- Undifferentiated lymphoepithelial carcinoma, histology. Proliferation of large undifferentiated epithelial cells are observed, 
forming large solid sheets. No glandular or squamous differentiation is observed. A fine vascular stroma is present with lympho-plasmocytic 
infiltration. Necrosis is also evident. (ob. 10×, hematoxylin and eosin)
Figure 7- Marginal zone B-cell lymphoma, clinical aspect. A left-
sided, relatively well-demarcated preauricular, firm, non-tender 
mass are observed. Overlying skin is shiny
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have considerably improved.
Case 4
A 73-year-old female patient was examined at 
the outpatient clinic with a right facial painless mass, 
showing accelerated growth in the past two months, 
that has been present for two years, without prior 
history of neoplastic or autoimmune disease. Physical 
examination revealed a mass located at the lower pole 
of the right parotid, with greatest diameter of about 4 
cm, having a firm structure, not attached to adjacent 
structures, without right facial nerve involvement 
(Figure 7). Computed tomography with contrast 
material revealed a nodule of 33 mm greatest diameter 
located within the right parotid gland parenchyma, 
without direct contact with major vascular elements 
of the neck and without nearby enlarged lymph nodes. 
FNAC was suggestive of lymphoproliferative lesion, 
composed of numerous monomorphic lymphoid cells 
within a background of non-specific inflammatory 
Figure 8- Marginal zone B-cell lymphoma, cytology. Smears are composed of two distinct lymphoid cell populations, both having indistinct 
cellular margins. One is composed of medium sized, containing relatively large nucleus, with atypical nuclear borders, occasional nuclear 
molding, irregular chromatin, occasional large nucleoli. The other consists of normal looking, small mature lymphocytes. Neoplastic cells 
apparently are clustered, however a propensity for decohesion is readily observed (obj. 20×, Papanicolaou stain)
Figure 9- Marginal zone B-cell lymphoma, histology. No characteristic architectural feature of normal lymphoid tissue can be observed, 
monocytoid, large centrocyte-like B cells are observed. Tumor cells have moderately abundant pale cytoplasm, mostly irregular nuclei with 
clumped chromatin (ob. 10×, hematoxylin and eosin stain)
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cells (Figure 8).
Superficial parotidectomy was performed with 
facial nerve preservation. Histology revealed a 
lymphoproliferative process consisting of small 
monomorphic cells, mostly displaying monocytoid 
and occasionally plasmacytoid features, present 
predominantly among follicles and within sinuses 
(Figure 9). Monocytoid lymphoid cells were CD20 
positive B cells, within a background of CD3, 
CD5 positive reactive T lymphocytes. CD23 and 
CD10 expression highlighted residual germinal 
centers. Tumor cells showed low proliferative index 
(10%, as assessed by Ki67). Bcl-6, CyclinD, pan-
cytokeratin were all negative. Based on histology 
and immunophenotype, a diagnosis of marginal zone 
lymphoma was made. The patient was referred to the 
Hematology Department, where he received specific 
oncologic treatment, including chemotherapy.
Discussion
Tumors of the salivary gland in general, and 
malignant tumors in particular, frequently present as 
painless swelling associated with symptoms related 
to facial nerve palsy (in 10-15% of cases), pain (in 
10-29% of patients), and fixation to deep structures. 
These clinical features are usually suggestive of local 
or regional tumor invasion9.
FNAC is an important method in the preoperative 
assessment of salivary gland lesions. Compared with 
excisional biopsy, it is easier to perform, safer, and has 
practically no complications24. Virtually, all head and 
neck masses, including salivary gland tumors may be 
assessed by FNAC, offering preoperative morphological 
assessment. Its less invasive nature makes it suitable 
for the pediatric population as well. Clinical studies 
have shown that aspiration cytology of salivary gland 
tumors has a sensitivity between 60-100% and a 
specificity between 90-100% in the diagnosis of these 
lesions4. Nevertheless, rare salivary gland tumors, 
including rare histological variants of common tumors, 
limit the diagnostic accuracy of FNAC3.
In rare malignant tumors that represent diagnostic 
challenges, FNAC alone may not be enough for 
adequate preoperative assessment. Moreover, 
sampling difficulties or other technical limitations 
may also hamper cytological diagnosis, including 
numerous histological variants and overlaps, making 
histological diagnosis often difficult. The use of 
immunohistochemistry greatly helps in diagnosis on 
such cases26. This study aimed to present some rare 
entities that may pose a diagnostic challenge during 
cytological evaluation.
Myoepithelial carcinoma is such a rare salivary 
gland tumor, consisting almost exclusively of tumor 
cells showing myoepithelial differentiation. It is 
clinically characterized by infiltrative growth and 
increased metastatic potential. Considered the 
malignant counterpart of myoepithelioma, most are in 
the parotid gland5. More than two thirds of the tumors 
with myoepithelial differentiation are benign8. It may 
reoccur, or on a pre-existing pleomorphic adenoma or 
myoepithelioma. Only a few clinical case series have 
been published so far18,27. Currently accepted diagnostic 
criteria include exclusive myoepithelial differentiation 
and tumor infiltration of surrounding soft tissues and 
salivary gland parenchyma29. Cytological features 
are diverse and not always include obvious signs of 
malignancy. There may be a plethora of cytological 
features, such as epithelioid, spindle, plasmacytoid, 
and even clear cells that were all described in FNAC 
smear obtained from such cases10,29.
In our case, despite the absence of specific 
features, unequivocal atypical nuclear features were 
present. Cytological diagnosis is difficult partly because 
of the presence of other lesions that may contain 
cells with myoepithelial differentiation1. Histology is 
definitive for the final diagnosis and, in combination 
with immunohistochemistry, aids in determining the 
myoepithelial differentiation of tumor cells. Most 
studies suggest alpha-smooth-muscle actin (SMA) and 
calponin as the most useful markers of myoepithelial 
differentiation. A combined use of these markers with 
others is recommended14. In our case, tumor cells 
expressed cytokeratin 5/6 and cytokeratin 7, SMA, 
S-100 protein, and p63, but they were negative for 
desmin.
The prognosis is variable with high rates of 
relapse and a propensity for distant metastasis. Thus, 
myoepithelial carcinoma is considered a high grade 
malignancy, with unpredictable behavior. Most tumors 
have an ability for extensive local infiltrative growth 
and destruction of nearby tissues11.
Oncocytic carcinoma is another rare neoplasm 
with less than 50 reported cases. It is considered a 
highly malignant neoplasm with tendency for local 
infiltrative growth and perineural invasion, frequent 
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local metastasis in cervical lymph nodes and distant 
metastasis to central nervous system, bones, liver, 
and lungs19. It may pose a real challenge to the 
cytopathologist since oncocytic cellular change is not 
infrequent in salivary gland lesions, including reactive 
non-neoplastic changes. Such tumors include basal 
cell adenoma, pleomorphic adenoma, myoepithelioma, 
cystadenoma, canalicular adenoma, Warthin’s tumor, 
acinar cell carcinoma, and mucoepidermoid carcinoma. 
However, a purely oncocytic tumor with associated 
nuclear features suggestive of malignancy should raise 
the possibility of oncocytic carcinoma7.
Cytological features were unspecific in our case, 
except that it highlighted oncocytic cells and nuclear 
features suggestive of malignancy.
Histological  examinat ion combined with 
immunohistochemistry offers a definitive diagnosis. 
Tumor cell are not only strongly reactive with 
mitochondrial antigen, but also express cytokeratin 
AE-1/AE-3, cytokeratin 7, CEA, EMA, and p63. The 
prognosis is difficult to assess due to the small number 
of published cases. Nevertheless, it is considered poor 
owing to frequent recurrences and early metastasis5.
Lymphoepithelial carcinoma represents less than 
0.5% of malignant tumors of the salivary glands and is 
currently considered a variant of anaplastic carcinoma 
with characteristic dense lymphoid stroma28. Clinical 
studies have demonstrated a higher prevalence 
among the Southeast Asia and Arctic region native 
populations. Its link to Epstein-Barr virus infection 
was documented; however, this association does 
not show endemic characteristics in all cases5,21. 
Secondary determination of an undiagnosed mucosal 
lymphoepithelial carcinoma (usually nasal) should 
also be ruled out2.
Cytological features of our case were inconclusive for 
a certain diagnostic group, and it was labeled as a poorly 
differentiated malignant neoplasm with prominent 
reactive lymphoplasmocytic background. Histological 
diagnosis of lymphoepithelial carcinoma is partly based 
on the recognition of lymphoepithelial nests, similar 
to those present in benign lymphoepithelial lesion, 
displaying clear-cut atypia. Differential diagnosis 
is difficult due to overlapping features; it includes 
amelanotic melanoma, large cell lymphocytic and 
histiocytic neoplasms, and metastatic tumors affecting 
intraparotid lymph nodes as well. Undifferentiated 
lymphoepithelial carcinoma cells are cytokeratin 
positive, while lymphoid malignancies are negative, for 
cytokeratins and express leukocyte common antigen22. 
Lymphoepithelial carcinoma has a strong tendency to 
metastasize, first to the parotid nodes, followed by 
the upper cervical and retro-auricular lymph nodes, 
later to the supraclavicular and paratracheal nodes. 
Distant metastases usually involve the lungs, liver, 
bones, and brain. It has a better prognosis than other 
undifferentiated carcinomas of the salivary glands, 
perhaps because of the lymphoid stroma, which has 
a role in limiting the tumor’s aggressiveness28.
Marginal zone lymphoma is an extra nodal low 
grade B-cell non-Hodgkin lymphoma that may affect 
the parotid gland. Other than the stomach, the salivary 
gland is one of the most common sites involved by 
extra nodal marginal zone lymphomas of mucosa-
associated lymphoid tissue (MALT)16. Characteristically, 
it presents as a painless, progressively growing mass13. 
Most marginal zone lymphomas appear within the 
background of a chronic lymphoid infiltrate, possibly 
due to a long lasting inflammatory stimulus (such as 
benign lymphoepithelial lesion or Sjögren’s syndrome), 
although it may present without evidence of previous 
condition23.
Primary lymphomas of the salivary gland are rare, 
about 4.7% of all lymphomas. Most are non-Hodgkin 
(MALT) lymphomas and occur in the parotid. Clinical 
presentation is nonspecific, therefore, preoperative 
assessment by FNAC is necessary. Lymphomas, in 
general, are difficult to diagnose by FNAC alone due 
to overlapping morphological features, lack of tissue 
architecture13. Nevertheless, the cytologist must be 
familiar with the cytological features of lymphomas, 
since therapy is different compared to an epithelial 
tumor23.
In our case, cytology suggested malignant 
lymphoproliferative lesion. Definitive diagnosis 
was obtained by histology, completed with 
immunohistochemistry. Marginal zone lymphoma 
diagnosis is difficult even on histology, and is based 
primary on excluding other lymphomas with specific 
markers. Tumor cells are positive for CD20 and CD79a 
or abnormal expression of CD43, and negative for 
CD5, CD10 and Cyclin D1. The prognosis of marginal 
zone lymphoma of the parotid gland is usually better 
than other extra nodal lymphomas. Even patients with 
advanced disease have relatively good survival13,31. 
Some studies found that prognosis is better in cases 
that arise in the background of Sjögren’s syndrome17.
FNAC is a valuable diagnostic tool that offers 
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the surgeon the ability to risk-stratify patients, to 
counsel them appropriately, and to avoid surgery in 
selected cases. Moreover, should FNAC confidently 
prove the existence of a benign process, facial nerve 
preservation must be attempted20. It is important to 
mention that, to maintain its high diagnostic accuracy 
as emphasized by Díaz, et al.12 (2014), all personnel 
involved in the process of salivary gland FNAC need to 
be continuously trained in this rather challenging area 
of diagnostic cytology30,33. Salivary gland cytology is 
an exciting branch of cytology that over the years has 
matured for the development of its own unified system 
for reporting, the Milan classification25.
Conclusion
The primary role of FNAC in salivary gland tumors 
is to offer a morphological diagnosis whenever that is 
possible. This is possible in most cases; however, in 
rare neoplasms the cytological diagnosis is difficult, 
often being only indicative of the nature of the lesion 
rather than offering specific diagnosis. For cases 
with discrepancy between cytological and clinical 
impressions (especially in cases of rare malignant 
tumors, such as those presented herein), histological 
examination remains the gold standard.
Due to frequently overlapping histological features 
of various salivary gland neoplasms, the definitive 
diagnosis of rare salivary gland tumors (epithelial 
or non-epithelial) should always be made by 
histolopathology. Preoperative cytology is useful for 
the diagnostic triage of salivary masses but the precise 
diagnosis may sometimes be difficult to interpret by 
cytology alone. 
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